Status of risk factors for vascular dementia

Neuroepidemiology

Volumn 17, Issue 1, 1998, Pages 2-9

  Skoog, Ingmar ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Cerbrovascular disease; Demetria; Review; Risk factor; Stroke; Vascular dementia

Indexed keywords

ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; BRAIN INFARCTION; BRAIN ISCHEMIA; DIABETES MELLITUS; EDUCATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MENTAL STRESS; MULTIINFARCT DEMENTIA; OCCUPATIONAL EXPOSURE; REVIEW; RISK FACTOR; STROKE; WHITE MATTER;

BRAIN; DEMENTIA, VASCULAR; HUMANS; RISK FACTORS;

EID: 0031967265     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026147     Document Type: Review

References (89)

1. Skoog I: Risk factors for vascular dementia: A review. Dementia 1994;5:137-144.
2. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993; 43:250-260.
3. Skoog I: Blood pressure and dementia; in: Hansson L, Birkenhäger WH (eds): Handbook of Hypertension, vol 18: Assessment of Hypertensive Organ Damage. Amsterdam, Elsevier 1997; pp 303-331.
4. Lotz PR, Ballinger WE, Quisling RG: Subcortical arteriosclerotic encephalopathy: CT spectrum and pathologic correlation. Am J Neuroradiol 1986;7:817-822.
5. Skoog I, Palmertz B, Andreasson L-A: The prevalence of white matter lesions on computed tomography of the brain in demented and nondemented 85-year-olds. J Geriatr Psychiatry Neurol 1994;7:169-175.
6. Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A: A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328:153-158.
7. Wetterling T, Kanitz R-D, Borgis K-J: Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996;27: 30-36.
8. Amar K, Wilcock GK, Scott M: The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996;25:51-55.
9. Bowler JV, Hachinski V: Vascular cognitive impairment: A new approach to vascular dementia; in: Baillière's Clinical Neurology. London, Baillière Tindall, 1995, pp 357-376
10. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA: Dementia in stroke survivors in the Stroke Data Bank cohort: Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 1990;21:858-866.
11. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, Remien RH, Williams JB, Mohr JP, Hauser WA, Figueroa M: Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185-1193.
12. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M: Dementia three months after stroke: Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory (SAM) cohort. Stroke 1997;28:785-792.
13. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R: Risk of dementia after stroke in a hospitalized cohort: Results of a longitudinal study. Neurology 1994;44:1885-1891.
14. Breteler MMB, Claus JJ, Grobbee DE, Hofman A: Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam Study. BMJ 1994;308: 1604-1608.
15. Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, van Harskamp F, Tanghe HJL, de Jong PTVM, van Gijn J, Hofman A: Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 1994;44:1246-1252.
16. Skoog I, Berg S, Johansson B, Palmertz B, Andreasson L-A: The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds. Acta Neurol Scand 1996; 93:142-148.
17. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L: Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3,301 elderly people: The cardiovascular health study. Stroke 1996;27:1274-1282.
18. Skoog I: Blood pressure and dementia: A review. Biomed Pharmacother 1997;51:367-375.
19. Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Frishman WH, Fisher D, Katzman R: Women, myocardial infarction, and dementia in the very old. Neurology 1990;40:1102-1106.
20. U'Ren R, Riddle M, Lezak M, Bennington-Davis M: The mental efficiency of the elderly person with type II diabetes mellitus. J Am Geriatr Soc 1990;38:505-510.
21. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, Sueishi K, Tsuneyoshi M, Fujishima M: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995; 45:1161-1168.
22. Rocca WA, Hofman A, Brayne C, Breteler MM, Clarke M, Copeland JR, Dartigues JF, Engedal K, Hagnell O, Heeren TJ, Jonker C, Lindesay J, Lobo A, Mann A, Mölsä PK, Morgan K, O'Connor DW, da Silva Droux A, Sulkava R, Kay DW: The prevalence of vascular dementia in Europe: Facts and fragments from 1980-1990 studies. Ann Neurol 1991;30:817-824.
23. Ueda K, Kawano H, Hasuo Y, Fujishima M: Prevalence and etiology of dementia in a Japanese community. Stroke 1992;23:798-803.
24. Meyer JS, McClintic KL, Rogers RL, Sims P, Mortel KF: Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 1988;51: 1489-1497.
25. Kotsoris H, Barclay LL, Kheyfets S, Hulyalkar A, Dougherty J: Urinary and gait disturbances as markers for early multi-infarct dementia. Stroke 1987;1:138-141.
26. Lindsay J, Hébert R, Rockwood K: The Canadian Study of Health and Aging. Risk factors for vascular dementia. Stroke 1997;28:526-530.
27. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Odén A, Svanborg A: A 15-year longitudinal study on blood pressure and dementia. Lancet 1996;347:1141-1145.
28. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB: Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996;39:1392-1397.
29. Mari D, Parnetti L, Coppola R, Bottasso B, Reboldi GP, Senin U, Mannucci PM: Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease. Thromb Haemost 1996;75:216-218.
30. Kuriyama M, Takahashi K, Yamano T, Hokezu Y, Togo S, Osame M, Igakura T: Low levels of serum apolipoprotein A I and A II in senile dementia. Jpn J Psychiatry Neurol 1994;48:589-593.
31. Ott A, Breteler MMB, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A: Atrial fibrillation and dementia in a population-based study: The Rotterdam Study, Stroke 1997;28:316-321.
32. Meyer JS, Judd BW, Tawakina T, Rogers RL, Mortel KF: Improved cognition after control of risk factor for multi-infarct dementia. JAMA 1986;256:2203-2209.
33. Persson G, Skoog I: A prospective population study of psychosocial risk factors for late-onset dementia. Int J Geriatr Psychiatry 1996;11: 15-22.
34. Mortel KF, Meyer JS, Herod B, Thornby J: Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 1995;6:55-62.
35. Hagnell O, Franck A, Gräsbeck A, Öhman R, Otterbeck L, Rorsman B: Vascular dementia in the Lundby Study. 2. An attempt to identify possible risk factors. Neuropsychobiology 1993;27:210-216.
36. Jorm AF, Korten AE, Henderson AS: The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987; 76:465-479.
37. O'Connor DW, Pollitt PA, Hyde JB, Fellows J, Miller ND, Brook CP, Reiss BB, Roth M: The prevalence of dementia as measured by the Cambridge mental disorders of the elderly examination. Acta Psychiatr Scand 1989;79:190-198.
38. White L, Petrovitch H, Ross GW, Masaki KH, Abbott RD, Teng EL, Rodriguez BL, Blanchette PL, Havlik RJ, Wergowske G, Chiu D, Foley DJ, Murdaugh C, Curb JD: Prevalence of dementia in older Japanese-American men in Hawaii. The Honolulu-Asia Aging Study. JAMA 1996;276:955-960.
39. Gorelick PB, Brody J, Cohen D, Freels S, Levy P, Dollear W, Forman H, Harris Y: Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital-based patients. Arch Neurol 1993;50:714-720.
40. Tatemichi TK, Desmond DW, Paik M, Figueroa M, Gropen TI, Stern Y, Sano M, Remien R, Williams JBW, Mohr JP, Mayeux R: Clinical determinants of dementia related to stroke. Ann Neurol 1993;33:568-575.
41. Gorelick PB, Chatterjee A, Patel D, Flowerdew G, Dollear W, Taber J, Harris Y: Cranial computed tomographic observations in multi-infarct dementia: A controlled study. Stroke 1992;23:804-811.
42. Ladurner G, Iliff L, Lechner H: Clinical factors associated with dement in in ischaemic stroke. J Neurol Neurosurg Psychiatry 1982;45:97-101.
43. Del Ser T, Bermejo F, Portera A, Arredondo J, Bouras C, Constantinidis J: Vascular dementia. A clinicopathological study. J Neurol Sci 1990;96:1-17.
44. Censori B, Manara O, Agostinis C, Camerlingo M, Casto L, Galavotti B, Partziguian T, Servalli MC, Cesana B, Belloni G, Mamoli A: Dementia after first stroke. Stroke 1996;27: 1205-1210.
45. Loeb C, Gandolfo C, Croce R, Conti M: Dementia associated with lacunar infarction. Stroke 1992;23: 1225-1229.
46. Kokmen E, Whisnant JP, O'Fallon WM, Chu C-P, Beard CM: Dementia after ischemic stroke: A population-based study in Rochester, Minnesota (1960-84). Neurology 1996; 19:154-159.
47. Pasquier F, Leys D: Why are stroke patients prone to develop dementia? J Neurol 1997;244:135-142.
48. Chimowitz MI, Awad IA, Furlan AJ: Periventricular lesions on MRI. Facts and theories. Stroke 1989;20: 963-967.
49. Román GC: Senile dementia of the Binswanger type: A vascular form of dementia in the elderly. JAMA 1987;258:1782-1788.
50. Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR: Subcortical arteriosclerotic encephalopathy (Binswanger's disease): Computed tomographic, nuclear magnetic resonance, and clinical correlations. Arch Neurol 1985;42:951-959.
51. Lopez OL, Becker JT, Jungreis CA, Rezek D, Estol C, Boller F, DeKosky ST: Computed tomography - but not magnetic resonance imaging - identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol 1995;52:659-664.
52. Amar K, Lewis T, Wilcock G, Scott M, Bucks R: The relationship between white matter low attenuation on brain CT and vascular risk factors: A memory clinic study. Age Ageing 1995;24:411-415.
53. Pantoni L, Garcia JH: Pathogenesis of leukoaraiosis: A review. Stroke 1997;28:652-659.
54. Lindgren A, Roijer A, Rudling O, Norrving B, Larsson E-M, Eskilsson J, Wallin E, Olsson B, Johansson BB: Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke: A population-based study. Stroke 1994;25:929-934.
55. Räihä I, Tarvonen S, Kurki T, Rajala T, Sourander L: Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand 1993;87:286-289.
56. Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H: Vascular risk factors and leuko-araiosis. Arch Neurol 1987;44:42-47.
57. Schneider R, Ringelstein EB, Zeumer H, Kiesewetter H, Jung F: The role of plasma hyperviscosity in subcortical arteriosclerotic encephalopathy (Binswanger's disease). J Neurol 1987;234:67-73.
58. Erkinjuntti T, Sulkava R, Palo J, Ketonen L: White matter low attenuation on CT in Alzheimer's disease. Arch Gerontol Geriatr 1989;8: 95-104.
59. Chabriat H, Vahedi K, Iba-Zizen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, Levasseur M, Homeyer P, Mas JL, Lyon-Caen O, Tournier Lasserve E, Bousser MG: Clinical spectrum of CADASIL: A study of 7 families. Lancet 1995;346:934-939.
60. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC III: Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995;131:162-169.
61. Soneira CF, Scott TM: Severe cardiovascular disease and Alzheimer's disease: Senile plaque formation in cortical areas. Clin Anat 1996;9: 118-127.
62. Sparks DL, Hunsaker JC III, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR: Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990;11:601-607.
63. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ: Risk of dementia among persons with diabetes mellitus: A population-based cohort study. Am J Epidemiol 1997;145: 301-308.
64. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154.
65. Jendroska K, Poewe W, Daniel SE, Pluess J, Iwerssen-Schmidt H, Paulsen J, Barthel S, Schelosky L, Cervós-Navarro J, DeArmond SJ: Ischemic stress induces deposition of amyloid β immunoreactivity in human brain. Acta Neuropathol 1995;90:461-466.
66. Brun A, Englund E: A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study. Ann Neurol 1986;19:253-262.
67. Coffman J, Torello M, Bornstein R, Chakeres D, Bums E, Nasrallah H: Leukoaraiosis in asymptomatic adult offspring of individuals with Alzheimer's disease. Biol Psychiatry 1990;27:1244-1248.
68. Tang M-X, Jacobs D, Stern Y, Marder K, Scofield P, Gurland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
69. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997;277:813-817.
70. Lethem R, Orrell M: Antioxidants and dementia. Lancet 1997;349: 1189-1190.
71. Henderson AS: The risk factors for Alzheimer's disease: A review and a hypothesis. Acta Psychiatr Scand 1988;78:257-275.
72. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M: β-Amyloidmediated vasoactivity and vascular endothelial damage. Nature 1996; 380:168-171.
73. Corder EH, Saunders AM, Stritt-matter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261:921-923.
74. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
75. van Bockxmeer FM, Mamotte CDS: Apolipoprotein E4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-880.
76. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ: Apolipoprotein Ealleles, dyslipidemia, and coronary heart disease: The Framingham offspring study. JAMA 1994;272:1666-1671.
77. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
78. Amouyel P, Richard F, Cottel D, Amant C, Codron V, Helbecque N: The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett 1996;217:203-205.
79. Arregui A, Perry E, Rossor M, Tomlinson BE: Angiotensin converting enzyme in Alzheimer's disease: increased activity in caudate nucleus and cortical areas. J Neurochem 1982;82:1490-1492.
80. Ekeberg O, Kjeldsen SE, Eide I, Leren P: Childhood traumas and psychosocial characteristics of 50-year-old men with essential hypertension. J Psychosom Res 1990;34:643-649.
81. Meaney MJ, Aitken DH, van Berkel C, Bhatnagar S, Sapolsky RM: Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988; 239:766-768.
82. Sapolsky R, Armanini M, Packan D, Tombaugh G: Stress and glucocorticoids in aging. Endocrinol Metab Clin N Am 1987;16:965-980.
83. Olsson Y, Brun A, Englund E: Fundamental pathological lesions in vascular dementia. Acta Neurol Scand 1996;(suppl 168):31-38.
84. Wisniewski HM, Kozlowski PB: Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann NY Acad Sci 1982;396:119-131.
85. Hardy J, Mann D, Wester P, Winblad B: An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging 1986;7:489-502.
86. Kalaria RN, Golde TE, Cohen ML, Younkin SG: Serum amyloid P in Alzheimer's disease: Implications for dysfunction of the blood-brain barrier. Ann NY Acad Sci 1991;640: 145-148.
87. Ferrucci L, Guralnik JM, Salive ME, Pahor M, Corti M-C, Baroni A, Havlik RJ: Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 1996;44: 237-241.
88. Gale CR, Martyn CN, Cooper C: Cognitive impairment and mortality in a cohort of elderly people. Br Med J 1996;312:608-611.
89. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thai LJ; Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995;52: 702-708.